Corbion, a global leader in sustainable ingredients located in Amsterdam, has partnered with BRAIN Biotech AG from Zwingenberg, Germany, to advance the development of novel biobased antimicrobial compounds and their derivatives. This collaboration is set to enhance Corbion's ability to provide food manufacturers with preservation solutions that align with consumer demand for natural ingredients. “At Corbion, advancing the state of the art in nature-based ingredient technologies, proving and expanding on their value and efficacy, is essential to preserving what matters,” stated Domenico Vulcano, Vice President of Global Innovation at Corbion. He added, “One of the ways we continue to strengthen our investment in innovation is through establishing partnerships with other experts like those at BRAIN Biotech. We believe this kind of collaboration will help us bring the next paradigm-changing breakthroughs to market sooner.”

BRAIN Biotech AG contributes its expertise in specialty enzyme technology, microbial strain development, and bioprocess development to this collaboration. The company also functions as a technology licensing entity. Corbion offers extensive knowledge of food systems and biobased preservation technologies, along with valuable customer insights and advanced piloting and scale-up capabilities. “We are very pleased to partner with Corbion in expanding what’s possible with sustainable, bio-based solutions,” remarked Dr. Martin Langer, Managing Director & Executive Vice President at BRAIN Biotech AG. “We see a very strong affinity between our team at BRAIN and our collaborators at Corbion. Given our respective strengths, shared vision, and complementary areas of expertise, we expect this to be a fruitful collaboration that will deliver real impact for the world’s food manufacturers.”

‍